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Abstract
The autotransporters are a large and diverse family of bacterial secreted and outer membrane proteins, which are present in
many Gram-negative bacterial pathogens and play a role in numerous environmental and virulence-associated interactions.
As part of a larger systematic study on the autotransporters of Burkholderia pseudomallei, the causative agent of the severe
tropical disease melioidosis, we have constructed an insertion mutant in the bpss1439 gene encoding an unstudied
predicted trimeric autotransporter adhesin. The bpss1439 mutant demonstrated a significant reduction in biofilm formation
at 48 hours in comparison to its parent 10276 wild-type strain. This phenotype was complemented to wild-type levels by
the introduction of a full-length copy of the bpss1439 gene in trans. Examination of the wild-type and bpss1439 mutant
strains under biofilm-inducing conditions by microscopy after 48 hours confirmed that the bpss1439 mutant produced less
biofilm compared to wild-type. Additionally, it was observed that this phenotype was due to low levels of bacterial adhesion
to the abiotic surface as well as reduced microcolony formation. In a murine melioidosis model, the bpss1439 mutant strain
demonstrated a moderate attenuation for virulence compared to the wild-type strain. This attenuation was abrogated by in
trans complementation, suggesting that bpss1439 plays a subtle role in the pathogenesis of B. pseudomallei. Taken together,
these studies indicate that BPSS1439 is a novel predicted autotransporter involved in biofilm formation of B. pseudomallei;
hence, this factor was named BbfA, Burkholderia biofilm factor A.
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Introduction
Burkholderia pseudomallei is a motile, Gram-negative bacillus,
which is principally an environmental saprophyte of tropical and
sub-tropical soils and water. It is the causative agent of melioidosis,
a febrile illness with disease states ranging from acute pneumonia
or septicaemia to chronic or localised abscess formation. The
disease is acquired by subcutaneous inoculation, inhalation and
ingestion. Melioidosis has become an increasingly important
disease in endemic areas such as South East Asia and Northern
Australia causing a significant number of deaths despite antibiotic
treatment. B. pseudomallei has a large genome encoding many
virulence factors, including capsule, lipopolysaccharide (LPS),
flagella, quorum sensing (QS) systems and several protein secretion
systems, including type III and type VI pathways [reviewed in
[1,2]].
B. pseudomallei grows in microcolonies in vitro and in vivo for which
the production of exopolysaccharride have been implicated [3]. It
has been postulated that biofilm formation may allow bacterial
cells to evade the host immune system and persist within patients
causing chronic or relapsing disease. Melioidosis is refractory to
antibiotic therapy and B. pseudomallei biofilms have been shown to
have very high levels of resistance to antibiotics which are effective
against planktonic cells [4,5]. The quantity of biofilm produced by
B. pseudomallei is strain dependent [4,6,7] and affected by the
growth conditions. Interestingly, the addition of glucose (2–
50 mM) enhances biofilm formation [6]; the authors proposed
that this may in part explain why chronic and relapsing infections
are more common in diabetic patients with poor glycemic control
[8].
The relative effects of a variety of mutants on the formation of
biofilms have been tested. An acapsular wcbB mutant demonstrat-
ed wild-type levels of biofilm formation [4] while a second
acapsular wzm mutant had reduced biofilm formation in minimal
media but not in LB [9]. This may indicate that under certain
conditions, capsule is important for biofilm production; however,
the wzmmutant also demonstrated susceptibility to desiccation and
oxidative stress [9] which may indirectly affect biofilm formation.
An LPS O-antigen wbiI mutant also displayed wild-type levels of
biofilm which concurs with the observation that the level of biofilm
production by a strain does not correlate with the presence of O-
antigen observed by silver staining [4].
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An aflagellate fliC mutant demonstrated reduced biofilm
formation [4]. Additionally, a pkk (polyphosphate kinase) mutant
was found to be aflagellate and also demonstrated reduced biofilm
formation; however, this mutant also displayed reduced sensitivity
to oxidative stress [10]. To overcome the loss of flagella-based
motility, centrifugation of these two mutants onto an abiotic
surface was performed, but biofilm formation was still significantly
reduced. Microscopy demonstrated that no microcolony forma-
tion occurred for either strain while the pkk mutant also lacked
exopolysaccharide production [10]. These data indicate that
flagella play a role in microcolony formation. However, this
aflagellate phenotype can also be compensated by overexpression
of other factors which promote microcolony formation. A cpdA
mutant (encoding a c-di-GMP phosphodiesterase), with increased
intracellular GMP levels, lacks flagella but produced increased
levels of exopoolysaccharide, thus, more autoagglutination and
biofilm formation [11].
It is unclear from the multiple phenotypes of the cpdA mutant
whether c-di-GMP levels directly or indirectly affect biofilm.
Intracellular levels of c-di-GMP affect the QS system [11]. B.
pseudomallei has three QS synthases and five QS regulators [2]. A
bspI mutant, which cannot produce the major stationary phase QS
molecule C8HL, displayed reduced biofilm formation, as does a
mutant in its regulator bspR. When the secondary producer of
C8HL (bspI3) was inactivated, it also demonstrated reduced
biofilm formation although comparatively less than the bspI
mutant [12]. Biofilm levels could be restored to wild-type levels
by the addition of exogenous C8HL [12]; these data indicated that
one or more factors required for biofilm formation is/are
expressed under stationary phase conditions and that this
expression may be either directly or indirectly influenced by the
QS regulator(s). Another regulatory factor that has been identified
to potentially play a role in biofilm formation is the alternative
sigma factor sE [13]. Proteomic analysis of protein expression by a
B. pseudomallei rpoE mutant relative to its parent strain did not
identify any proteins with known or putative roles in biofilm
production [14].
To date, only one study has focused on genes directly involved
in biofilm formation as the mutations discussed above have
pleiotropic effects. A random mutagenesis study identified two
strains which produced very low levels of biofilm; the first mutant,
M6, had a transposon insertion within a gene encoding a putative
polysaccharide biosynthesis protein, and the second, M10, had an
insertion in gene encoding a putative sugar transferase [7]. These
mutants demonstrated wild-type virulence in the BALB/c
melioidosis model [7] and, although demonstrating some reduc-
tion in antibiotic diffusion and viability, still show biofilm-like
levels of antibiotic resistance [7,15]. However, these unexpected
results are likely to be caused by the mutagenesis system used in
this study; a subsequent paper by the same authors’ identified a
non-specific reduction in biofilm production due to the transposon
used [16]. Therefore, factors directly involved in biofilm forma-
tion, and the role of biofilm in virulence, remain to be elucidated.
The autotransporters (ATs) are a large and diverse family of
bacterial secreted and outer membrane proteins, which are present
in many Gram-negative bacterial pathogens and play roles in
numerous environmental and virulence-associated interactions
including persistence, adhesion, serum resistance and biofilm
formation. ATs utilise the Type V secretion mechanism, one of
seven recognised secretion pathways in Gram-negative bacteria. A
typical AT will have a 20–400 kDa passenger domain that
contains the effector functions and a 10–30 kDa b domain
facilitating translocation across the outer membrane [17]. ATs can
be further divided into classical ATs and trimeric autotransported
adhesins (TAAs). TAAs are so named because each protein
trimerises to form a single 12-stranded b barrel from their three 4-
stranded b barrel domains. The functional passenger domain of a
typical AT acts predominantly as an adhesin [17,18]. The B.
Table 1. Strains, plasmids and cell lines used in this study.
Strain, plasmid or cell line Characteristics Reference or source
B. pseudomallei:
10276 Clinical isolate (wild-type) Dr T. Pitt (Public Health
Laboratory Service, London, UK)
10276 (pME) 10276 harbouring the pME6032 plasmid This study
bpss1439 (bbfA) mutant 10276 harbouring a pKNOCK-Kan single cross-over insertion in bpss1439 (bbfA) This study
bpss1439 (bbfA) mutant (pME) 10276 harbouring a pKNOCK-Kan single cross-over insertion in bpss1439 (bbfA)
and the pME6032 plasmid
This study
bpss1439 (bbfA) mutant (pME-1439) 10276 harbouring a pKNOCK-Kan single cross-over insertion in bpss1439 (bbfA)
and the pME6032 plasmid containing a full-length copy of bpss1439
This study
E. coli:
S17-1 lpir Laboratory strain (lpir hsdR pro thi; chromosomal integrated RP4-2 Tc::Mu Km::Tn7). [36]
Plasmids:
pKNOCK-Kan 2.2 kb, KanR, lpir-dependent vector (oriR6K) with RP4 oriT [23]
pKNOCK-Kan-bpss1439 pKNOCK-Kan containing a 623 bp internal fragment of bpss1439 (bbfA) This study
pME (pME6032) 9.8 kb, TetR, pVS1 derived shuttle vector with IPTG inducible ptac promoter [24]
pME-1439 pME6032 containing the full-length (4593 bp) bpss1439 (bbfA) gene,
including 146 bp upstream
This study
Eukaryotic cell lines:
J774.2 Murine macrophage-like cells ECACC 85011428
A549 Human lung airway epithelial cells ECACC 86012804
doi:10.1371/journal.pone.0079461.t001
BPSS1439 and Biofilm Formation by B. pseudomallei
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pseudomallei K96243 genome contains eleven predicted ATs, based
on sequence similarity to known ATs [19], of which nine are
predicted to be TAAs [20]. Only two TAA adhesins have been
characterised; mutants in boaA and boaB are impaired in epithelial
adhesion while expression of recombinant BoaA and BoaB in a
heterologous E. coli host increased the adhesive phenotype of the
bacterial cells [21]. As part of a larger systematic study on the
autotransporters of B. pseudomallei, we have constructed an
insertion mutant in the bpss1439 gene encoding an unstudied
predicted TAA. This mutant was found to be affected in its ability
to form biofilm, and demonstrated a moderate attenuation for
virulence compared to the wild-type strain in the acute murine
melioidosis model, suggesting that production of biofilm may play
a role in virulence of B. pseudomallei.
Materials and Methods
Ethics Statement
All investigations involving animals were carried out according
to the requirements of the Animal (Scientific Procedures) Act
1986. Ethical approval was granted by our local (Defence Science
and Technology Laboratory, University of Leicester) ethical
review process according to the requirements of the Animal
(Scientific Procedures) Act 1986. Predetermined humane end
points were employed where possible and animals were culled via
cervical dislocation according to schedule 1 of the Animal
(Scientific Procedures) Act 1986.
Bacterial strains, plasmids, media and growth conditions
All bacterial strains and plasmids reported in these studies are
listed in Table?Bertani (LB) broth with shaking or on 1.5% w/v
agar at 37uC. Cultures were supplemented with antibiotics and/or
10 mM isopropyl-b-D-thiogalactopyranoside (IPTG) as required;
kanamycin was used at a final concentration of 500 mg/ml and
tetracycline at 25 mg/ml.
Recombinant DNA techniques
Plasmid DNA isolation, PCR fragment purification and gel
extraction were performed using Bioline kits as per manufacturer’s
instructions. Genomic DNA was isolated from B. pseudomallei as
previously described [22]. Restriction endonucleases and DNA
modifying enzymes (New England Biolabs) were used as per
manufacturer’s instructions. PCR amplifications were performed
using Advantage Taq (Clontech) or Taq DNA polymerase (New
England Biolabs) in accordance with manufacturer’s instructions.
DNA sequencing was carried out at the Protein and Nucleic Acid
Laboratory of the University of Leicester.
The bpss1439 single cross-over insertion mutant was generated
using pKNOCK-Kan [23] as described previously. Briefly, an
internal fragment of the bpss1439 gene was amplified by PCR from
B. pseudomallei 10276 using primers EF (59 TCCGAGGGATC-
CAACGGCAAGCGCGGCGGC) and M5R (59
CCCGTCTCTAGAGAAGTGGAAAGCGAGGTCAG). The
PCR product containing the internal fragment was digested with
BamHI and XbaI alongside the pKNOCK-Kan plasmid and
ligated to form pKNOCK-Kan-bpss1439. This recombinant
plasmid was introduced into B. pseudomallei 10276 via conjugation
from E. coli S17-1lpir [23] and insertion inactivation of bpss1439
was confirmed by PCR and sequencing.
To allow for in trans complementation, the full-length bpss1439
gene was amplified by PCR from B. pseudomallei 10276 using
primers FC (59 ATCTCTAGACCATGATGAACAAGATCTA-
TAAAACC) and RC (59 ATCGGATCCTTCATGTGCTT-
GAGCCAGTC). The PCR product containing the bpss1439 gene
was digested with NcoI and BamHI and ligated into similarly
digested pME6032 [24] under the control of a lac promoter to
form pME6032-bpss1439 (pME-1439).
Biofilm assays
Biofilm formation on an abiotic polystyrene surface was studied
using 96-well trays (Nunc) as described previously [10]. Briefly,
overnight cultures of B. pseudomallei strains were diluted 1:10 in LB
and incubated at 37uC under static conditions for 48 h. Biofilms
were washed in distilled water, stained with 1% w/v crystal violet
for 5 minutes, washed and then solubilised in 96% v/v ethanol.
The degree of biofilm formation stained by the crystal violet was
determined by the optical density at 595 nm. Eight experimental
replicates were assessed in triplicate experiments.
Microscopic analysis of biofilms
Biofilms were allowed to form on 20 mm glass coverslips
(Menzel Gla¨ser) within 24 well trays (Nunc) as described above
and fixed overnight in 4% w/v paraformaldehyde or 2.5% v/v
glutaldehyde for examination by light microscopy or scanning
electron microscopy (SEM) respectively. For light microscopy,
fixed biofilms grown on coverslips were visualised with a Peroidic
Acid Scheiff stain (Sigma) and examined using a Nikon Diaphot
300 inverted microscope with a 6100 oil immersion lens. For
SEM, fixed biofilm grown on coverslips were dehydrated, sputter
coated with gold and examined using a Hitachi S3000H SEM
(Leicester Imaging Technologies, University of Leicester). At least
ten fields of view were assessed in duplicate experiments.
Phenotypic testing
The bpss1439 mutant and its parent wild-type 10276 strain were
assessed for various phenotypes which may impact of biofilm
formation using published methods. Phenotypes examined were:
polysaccharide capsule using mAb staining [25], LPS using silver
stain [4], flagella and pili using motility plates [10], oxidative stress
using peroxide sensitivity [13], osmotic stress using NaCl sensitivity
[13], desiccation using drying sensitivity [9] and exopolysaccharide
production using Congo Red binding [11]. Also in vitro attachment
and net intracellular survival assays were performed using
immortalised A549 human airway epithelial cells [11] and
J774.2 murine macrophage-like cells [13].
Figure 1. The arrangement of the bpss1439 operon. The bpss1439 gene is located in an operon with two downstream genes, bpss1442 and
bpss1443; both which encode hypothetical proteins of no significant database hits. The closest orthologue to bpss1439 is the upstream gene
(bpss1434) encoding another unstudied predicted TAA.
doi:10.1371/journal.pone.0079461.g001
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Assessment of virulence in mice
Three independent animal trials to assess the virulence of the
bpss1439 mutant were performed as follows.
Groups of six BALB/c mice (6–8 weeks old) were challenged by
the intra-peritoneal route with either the wild-type or bpss1439
mutant at 3.56105 CFU or 3.076105 CFU. Mice were monitored
for signs of disease over a 35 day period and humanely culled
when pre-defined end-points were reached; a log-rank (Mantel-
Cox) test was used to evaluate the statistical significance of time to
death between the wild-type and bpss1439 mutant.
Six groups of five BALB/c mice (6–8 weeks old) were separately
challenged by the intra-peritoneal route with the bpss1439 mutant
at doses rising in ten-fold increments from 8.86102 to 8.86107
CFU. The wild-type 10276 parent strain was tested at a single dose
(36106 CFU) to confirm consistent results with the previously
determined MLD of 1.66104 CFU from 2004 and 2009 (data not
shown). Mice were monitored for signs of disease over a 35 day
period and humanely culled when pre-defined end-points were
reached. The medium lethal dose for the bpss1439 mutant was
determined using the Reed and Meunch calculation based on
cumulative infections.
Groups of three BALB/c mice (6–8 weeks old) were challenged
by the intra-peritoneal route with an equal ratio of wild-type
harbouring the pME6032 vector and the bpss1439 mutant
harbouring either the pME6032 vector or the pME-1439
complementation vector (46105 CFU). Mice were monitored for
signs of disease over the 24 hour experimental period and then
humanely culled. Livers and spleens were harvested and plated for
bacterial recovery. Colonies were patched onto kanamycin and
tetracycline agar plates and the percentage of in vivo growth of the
bpss1439 mutant versus the wild-type was determined by
subtracting the number of tetR, kanR (bpss1439 mutant harbouring
pME6032 or pME-1439) colonies from the number of tetR, kanS
(wild-type harbouring pME6032) colonies. Statistical significance
was assessed using Student’s T test.
Results and Discussion
Bioinformatic analysis of BPSS1439, an unstudied
predicted TAA
The B. pseudomallei K96243 genome encodes nine predicted
TAAs; the bpss1439 gene is located on chromosome two and has
been predicted to be located in an operon with two downstream
genes, bpss1442 and bpss1443 (C. Ong, personal communication;
[26]) (Figure?. Both of these downstream genes are annotated as
encoding hypothetical proteins which lack homology to known
proteins in available databases. As a result of revision of the
K96243 genome annotation, there are no longer genes numbered
bpss1440 or bpss1441. The closest orthologue to bpss1439 is the
upstream gene bpss1434, which is predicted to encode another
unstudied TAA; bpss1434 is a significantly larger gene of 7899 bp
(versus the 4581 bp bpss1439). These genes share 85% identity
with most of the variation occurring in the 59 end of the gene
which encodes the functional N-terminal region of the predicted
TAA (data not shown) suggestive that these genes encode TAAs
with divergent functions. The high degree of sequence similarity
between bpss1439 and bpss1434 has resulted in the mistaken earlier
observation that orthologues of both these genes are present in B.
thailandensis E264 [27], which in fact only has a full-length
orthologue for bpss1434 and a truncated pseudogene (639 bp) in
place of bpss1439. Interestingly, the bpss1439 orthologue also
occurs as a pseudogene in B. mallei ATCC 23344 (BMAA0810;
459 bp). Furthermore, truncation of bpss1439 also occurs within
some of the sequenced B. pseudomallei strains (14, 112, 91,
NCTCC13177, BCC215, 7894, DM98, B7210, BPC006, 1106b,
668); these pseudogenes not only vary in length but in whether
Figure 2. The bpss1439mutant displayed reduced biofilm formation which was complemented by in trans bpss1439 expression. a. The
wild-type and bpss1439 mutant were grown in LB under static conditions at 37uC for 48 hours. Biofilms were stained with 1% w/v crystal violet,
solubilised and quantified using an optimal density reading at 595 nm. Results are plotted with standard deviation error bars from triplicate
experiments each consisting of eight experimental replicates; the p value was calculated using a paired Student’s T test. b. The trans-complemented
bpss1439 mutant (pME-1439), as well as the wild-type and bpss1439 pME strain, were also assessed for biofilm production as described previously.
doi:10.1371/journal.pone.0079461.g002
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they are 59 or 39 truncations. Other strains have a full-length copy
of the bpss1439 gene (MSHR346, K96243, 1106a, 1710a, 1710b,
MSHR305, 1026b) with small size differences due to variable
numbers of repeat regions (1488 bp to 1616 bp). Agarose gel
electrophoration of the PCR amplification of the bpss1439 gene
from the 10276 strain used in this study indicated that a full-length
copy was present on the genome (data not shown).
The bpss1439 gene encodes for a 1530 aa predicted TAA which
contains an extended signal peptide (pfam13018) with a predicted
cleavage site at 24 aa, and the characteristic C-terminal domains
annotated as HIM (pfam05662; short motif found in invasins and
haemoagglutinins) and YadA-like (pfam03895; beta barrel region)
[28]. The remainder of the protein largely consists of low-
complexity repeat regions which form the neck structure
responsible for ensuring the adhesin domains are accessible to
their host target. A single cross-over insertion mutation disrupting
the bpss1439 gene was constructed using the sucide vector
pKNOCK-Kan in which a 623 bp internal fragment of bpss1439
was cloned. The resulting plasmid was recombined into bpss1439;
sequencing of an amplicon of the mutated region on the
chromosome confirmed the disruption of the gene at a point
which would produce a transcript encoding a severely truncated
207 aa protein lacking both a portion of the passenger domain and
the C-terminal domain responsible for mediating outer member
translocation (data not shown).
The bpss1439 mutant displayed reduced biofilm
formation compared to the wild-type strain
The reported functions of TAAs includes roles in both
autoagglutination and biofilm formation [29]. To assess if the
unstudied predicted TAA encoded by bpss1439 has a role in either
of these phenotypes, a comparative analysis of the bpss1439mutant
and its parent wild-type 10276 strain was performed. The strains
were incubated for 48 hours in LB at 37uC under static conditions
and monitored for altered autoagglutination by the measurement
of the optical density of the growth media; the bpss1439 mutant
and wild-type strains demonstrated the same level of autoagglu-
tination (data not shown). However, when these cultures were
Figure 3.The bbfA mutant demonstrated reduced adhesion and microcolony formation. A. The wild-type, bbfA mutant and trans-
complemented bbfA mutant (pME-1439), along with the control wild-type and bbfA mutant strains harbouring pME, were grown in LB under static
conditions at 37uC for 48 hours. Biofilms were stained for exopolysaccharide using the periodic acid-Schiff protocol and examined by light
microscopy. B. The wild-type and bbfA mutant biofilms were also fixed with 2.5% v/v glutaldehyde and examined by scanning electron microscopy.
doi:10.1371/journal.pone.0079461.g003
Table 2. Comparison of the bbfA mutant with other reported biofilm reduced strains.
Mutant Annotation Source Other phenotypes Cell lines
wzn ABC transporter [9] acapsular, Q oxidative survival, desiccation
fliC Flagellin [4] aflagellate
cpdA c-di-GMP phosphodiesterase [11] aflagellate, q EPS{, autoagglutination Q A549 & THP1 invasion
pkk polyphosphate kinase [10] aflagellate, Q oxidative survival
rpoE Alternative sigma factor [13] Q oxidative & osmotic survival Q J774 invasion
bspI QS synthase 1 [12] no QS 1
bspI3 QS synthase 3 [12] no QS 3
bspR QS regulator 1 [12] no QS 1
bbfA TAA This study wt A549 & J774 invasion
{EPS = exopolysaccharide.
doi:10.1371/journal.pone.0079461.t002
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assessed for their ability to form biofilms, the bpss1439 mutant
demonstrated a significant (p,0.001) reduction in biofilm forma-
tion at 48 hours in LB at 37uC compared to the wild-type strain
(Figure?. This same phenotypic profile was found to occur at
temperatures of 27uC and 30uC, as well as in minimal media and
LB enriched with 50 mM glucose (data not shown).
To confirm that the observed reduction in biofilm formation is
due to the disruption of bpss1439, rather than downstream genes in
the operon (Figure?, the bpss1439 mutant was complemented in
trans. A full-length copy of the bpss1439 gene was cloned into the
inducible pME6032 vector; the resultant plasmid (pME-1439) was
transformed into the bpss1439 mutant by electroporation. Addi-
tionally, B. pseudomallei wild-type and the bpss1439 strain harbour-
ing empty pME6032 (pME) vector were constructed as controls to
account for any potential effects of the plasmid per se on biofilm
formation. All strains were tested and found to display wild-type
levels of in vitro growth under the conditions used for the biofilm
assays (Figure S1). Biofilm assays were repeated as described
previously and the expected levels of biofilm were observed for the
wild-type (pME) and bpss1439 (pME) strains. However, biofilm
production by the bpss1439 (pME-1439) strain was restored to
wild-type levels in the presence of inducer (Figure?. Therefore, it
can be concluded that bpss1439 is a novel factor involved in biofilm
formation of B. pseudomallei. We have therefore named this gene
bbfA, Burkholderia biofilm factor A.
The bbfA mutant demonstrated reduced adhesion and
microcolony formation
Microscopy was used to confirm and examine the defect in
biofilm production by the bbfA mutant. The wild-type and bbfA
mutant, along with the control strains harbouring pME or pME-
1439, were grown on glass coverslips under static conditions in LB
at 37uC for 48 hours. Biofilms were stained for exopolysaccharide
using the periodic acid-Schiff protocol. When grown under
biofilm-inducing conditions, the bbfA mutant demonstrated
reduced adhesion as seen by lower total bacterial numbers, as
well as reduced microcolony formation as noted by the lack of
clumping or autoagglutination of bacterial cells in comparison
with the wild-type (Figure?. As previously found with the crystal
violet biofilm assay, the wild-type (pME) and the complemented
bbfA (pME-1439) strains demonstrated wild-type levels of biofilm
production with extensive microcolony formation while the bbfA
mutant and bbfA (pME) strains displayed reduced adhesion and
microcolony formation (Figure?.
Biofilm formation of the wild-type and bbfA strains was further
examined by SEM (Figure?. These images were congruent with
the periodic acid-Schiff staining with the bbfA mutant demonstrat-
ing reduced adhesion and microcolony production in comparison
to the wild-type. Additionally, evidence of biofilm maturation in
terms of the depth of the wild-type biofilm formation is clearly
lacking in the bbfA mutant samples grown in biofilm-inducing
conditions. Therefore, bbfA appears to play a role in the initial
adhesion of B. pseudomallei to an abiotic surface based on reduced
bacterial numbers at the 48 hour time-point of biofilm formation.
The bbfA mutant did not demonstrate any of the
additional phenotypes reported for other biofilm
reduced mutant strains
All previously characterised B. pseudomallei mutants with reduced
ability to form biofilms also showed pleiotropic effects on multiple
other phenotypes. Therefore, to further understand whether the
BbfA protein acts directly in biofilm formation, the following
phenotypes were examined: polysaccharide capsule (monoclonal
antibody staining), LPS (silver stain), flagella and pili (swimming,
swarming and twitching motility plates), oxidative stress (peroxide
sensitivity), osmotic stress (NaCl sensitivity), dessication (viability
post-drying) and exopolysaccharide production (Congo red
binding). Additionally, the bbfA mutant was tested for net
intracellular replication in both epithelial A549 and macrophage
J774.2 cell lines. The bbfA mutant was found to display wild-type
characteristics for all of these phenotypes (Table? Figure S2).
These data suggest the adhesion phenotype of BbfA-mediated
biofilm formation described earlier is directly responsible for the
reduced production of biofilm in the bbfA mutant.
The bbfA mutant exhibited an attenuation for virulence
in the BALB/c murine melioidosis model compared to the
parent strain
To assess the role of biofilm formation in the pathogenesis of B.
pseudomallei, the bbfA mutant was tested for virulence in a murine
melioidosis model. Groups of six BALB/c mice were challenged
via the intra-peritoneal route and median time to death was
determined by the Mantel-Cox log-rank test at 35 days post-
infection (Figure?. Compared to mice infected with the parent
10276 wild-type, the mice challenged with the bbfA mutant
demonstrated a significant delay in time to death, with a mean
survival time of 3.5 days versus 2 days for the wild-type (p=0.03).
However, this delay in time to death could, in part, be a product of
the marginally lower inoculum (3.076105 CFU for bbfA vs.
3.56105 CFU for the wild-type); therefore, subsequent animal
studies were performed. Six groups of five BALB/c mice were
challenged via the intra-peritoneal route and the median lethal
dose (mice were humanely culled when pre-defined end-points
were reached) was determined by the using the Reed and Meunch
calculation based on cumulative lethal dose. Compared to the
parent 10276 wild-type, the bbfA mutant demonstrated a 13-fold
increase in medium lethal dose (2.096105 vs. 1.66104 CFU). To
confirm that this attenuation is directly linked to BbfA, in trans
complementation of the bbfA mutant was performed using a
competitive in vivo growth assay. An equal ratio of the wild-type
harbouring empty pME6032 vector and the bbfA mutant
harbouring either pME6032 or the pME-1439 complementation
vector was inoculated into groups of three BALB/c mice via the
intra-peritoneal route. Mice were humanely culled at 24 hours
post-infection and livers and spleens were harvested and plated for
Figure 4. Mice infected with the bbfA mutant demonstrated a
delay to death in comparison to those challenged with the
parental strain. Groups of six BALB/c mice were challenged via the
intra-peritoneal route and the median time to death was determined by
the Mantel-Cox log-rank test at 35 days post-infection. Mice inoculated
with the bbfA mutant had a mean survival time of 3.5 days versus 2 days
for those dosed with the wild-type (p= 0.03).
doi:10.1371/journal.pone.0079461.g004
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bacterial recovery. Colonies were patched to determine the
percentage of in vivo growth by the bbfA mutant versus the wild-
type strain by subtracting the number of tetR, kanR (bbfA mutant
harbouring pME6032 or pME-1439) colonies from the number of
tetR, kanS (wild-type harbouring pME6032) colonies. The bbfA
mutant harbouring empty pME6032 vector demonstrated reduced
in vivo growth compared to the wild-type harbouring pME6032.
However, this attenuation was abrogated by the complemented
bbfA mutant strain that displayed a comparable level of in vivo
survival to the wild-type harbouring pME6032, both within the
spleen (0.33%60.58% vs. 42.3%612.3%, p=0.004) and the liver
(0%60% vs. 42.5%620.6%, p=0.023). Bacteria isolated from the
liver and spleen of control mice infected with only the
complemented bbfA mutant strain demonstrated between 0% to
4% loss of the pME-1439 plasmid over the 24 hour experimental
period. These data suggest that bbfA-mediated biofilm formation
may play a subtle role in the pathogenesis of melioidosis. Future
studies could focus on whether biofilm production relates to
chronic disease rather than the acute infection seen in the BALB/c
melioidosis model [6], or when mice are challenged at a mucosal
surface rather than by a parenteral route. Alternatively, studies
could examine differences between strains; it has been previously
observed that B. pseudomallei strains demonstrate varying levels of
biofilm production, while B. mallei and B. thailandensis strains
produce relatively low levels of biofilm [4,6,7]. Therefore, it is of
interest to note that the bbfA gene occurs as a pseudogene in some
B. pseudomallei strains, as well as B. thailandensis and B. mallei, and
this may explain the variable biofilm levels seen.
Biofilm formation has been demonstrated to be of importance in
dynamic environments where there is a flow of fluid [30]. In
agreement with this observation, it has been proposed that the
ability of B. pseudomallei to form biofilms is important to its
colonisation of bore wells where it has been implicated in
melioidosis outbreaks [31]. While a role for biofilm formation
for persistence in the environment is often referenced [6,13,32], it
is important to remember that inoculation events, which are
essential for pathogenesis, occur at the environmental-host
interface. Furthermore, it is tempting to speculate, that similar to
the related pathogens Burkholderia cenocepacia [33] and Pseudomonas
aeruginosa [34], autotransporter-mediated biofilm formation of B.
pseudomallei may be involved in persistent infection of airways and
lungs. Unfortunately, little similarity (38% amino acid identity
overall) is seen with between BbfA and the B. cenocepacia biofilm
factor (BCAM0223); the functional domains of TAAs demonstrate
significant sequence divergence [35]. Yet an indication for a
potential role of biofilm production in the virulence of B.
pseudomallei is implicated by the identification of bbfA as one of
the subset of genes within the B. pseudomallei core genome which is
undergoing positive selection. This subset of genes, which
demonstrate an above-background rate of functional variation, is
enriched for genes with proposed or experimentally validated roles
in virulence [26]. Additionally, BbfA was recognised in convales-
cent sera from melioidosis patients indicating that it is expressed in
vivo [20]. One could propose that biofilm is important for the
unique lifestyle of B. pseudomallei in which it transitions between
survival, and persistence, in both the environment and various
hosts.
Supporting Information
Figure S1 The bbfA mutant, and the complemented
strains, demonstrate wild-type levels of in vitro growth.
a. The wild-type and bbfA mutant were grown in LB at 37uC for
48 hours; in vitro growth was quantified using optimal density
readings at 600 nm. Average values from biological triplicates are
plotted. b. The trans-complemented bbfA mutant (pME-1439), as
well as the wild-type and bbfA pME strain, were also assessed for in
vitro growth under biofilm production conditions. There is a
slightly lower final (48 h) OD600 reading for the wild-type strain
with pME; this strain demonstrates slightly higher biofilm
formation which may affect the OD reading at this time point.
(TIF)
Figure S2 Phenotypic analysis of the bbfA mutant. The
bbfA mutant and its parental wild-type 10276 strain were assessed
for various phenotypes which may impact of biofilm formation
using published methods. The following phenotypes were
examined: a. polysaccharide capsule (monoclonal antibody
staining), b. LPS (silver stain), c. flagella and pili (swimming,
swarming and twitching motility plates), d. exopolysaccharide
production (Congo red binding) and e. intracellular replication in
both epithelial A549 and macrophage J774.2 cell lines. The bbfA
mutant was found to display wild-type characteristics for all of
these phenotypes.
(TIF)
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